X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/bold-100-and-atr-inhibitors-as-a-new-avenue-for-pdac-targeting-at-aacr-2024-302108994.html
https://www.prnewswire.com/news-releases/bold-therapeutics-announces-positive-phase-2-safety-and-efficacy-results-for-bold-100-in-advanced-metastatic-colorectal-cancer-at-asco-gi-2024-302040707.html
https://www.prnewswire.com/news-releases/bold-therapeutics-presents-positive-interim-phase-2-results-for-bold-100-in-advanced-gastric-and-biliary-tract-cancer-at-asco-2023-301843600.html
https://www.prnewswire.com/news-releases/bold-therapeutics-to-present-positive-interim-gastric-and-biliary-tract-cancer-results-at-asco-2023-annual-meeting-301839011.html
https://www.prnewswire.com/news-releases/bold-therapeutics-presents-jaw-dropping-interim-phase-2-clinical-data-for-bold-100-in-the-treatment-of-advanced-colorectal-cancer-at-aacr-2023-301800233.html
https://www.prnewswire.com/news-releases/bold-therapeutics-to-present-best-in-class-phase-2-metastatic-colorectal-cancer-data-at-aacr-2023-301796021.html
https://www.prnewswire.com/news-releases/bold-therapeutics-attending-and-presenting-at-the-bio-europe-2022-and-bio-europe-2022-virtual-conferences-301649572.html
https://www.prnewswire.com/news-releases/bold-therapeutics-bold-100-early-mcrc-data-to-be-showcased-at-2022-metals-in-medicine-gordon-research-conference-301574858.html
https://www.prnewswire.com/news-releases/bold-therapeutics-to-present-at-bio-korea-2022-as-part-of-the-canadian-trade-delegation-301542707.html
https://www.prnewswire.com/news-releases/bold-100s-broad-potential-featured-at-the-aacr-annual-meeting-2022-301517878.html
Market Place
Share 
